Brief: Medigene, RXi To Collaborate On Therapeutic T Cells
Dec 11 (Reuters) - Medigene AG MDG1k.DE :
* MEDIGENE COLLABORATES WITH RXI PHARMACEUTICALS TO FURTHER
SHARPEN ITS THERAPEUTIC T CELLS
* TO EXPLORE PRECLINICALLY SYNERGIES BETWEEN RECOMBINANT T
CELL
TECHNOLOGIES OF MEDIGENE AND SELF-DELIVERING RNAI TECHNOLOGIES
FROM RXI
Source text for Eikon: ID:nPexWXjFJa
Further company coverage: MDG1k.DE
((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;))
Recent news on Medigene AG
See all newsBrief: Medigene Files Application For The Opening Of Insolvency Proceedings
Brief: Medigene Files Patent For Unique Nk-Specific TCR Construct With European Patent Office
Brief: Medigene AG Says Co Amends Financial Guidance For 2024
Brief: Medigene AG Expands Protection Of KRAS Library With Filing Of New Patent Application
Brief: Medigene H1 Revenue EUR 4.5 Million